BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 28, 2017
View Archived Issues
FDA confirms regulatory pathway to approval for bempedoic acid/ezetimibe
Read More
Phase II trial reveals efficacy of tadekinig alfa in some patients with adult onset Still's disease
Read More
Semnur successfully completes phase I/II pharmacokinetic bridging trial of SP-102
Read More
Zynerba Pharmaceuticals begins phase I program for ZYN-001
Read More
AZD-4785 demonstrates safety and efficacy in preclinical models of KRAS-driven cancer
Read More
Ra Pharmaceuticals reports initial data from study of RA-101495 in PNH
Read More
Kissei Pharmaceutical identifies NK1 receptor antagonists
Read More
Bavarian Nordic reports promising results from phase II study of MVA-BN RSV
Read More
Bristol-Myers Squibb presents formylpeptide receptor agonists
Read More
SP-1373 has beneficial effects on body and liver weight in obesity models
Read More
ST Pharm discloses tankyrase inhibitors
Read More
Luc Therapeutics presents NMDA receptor modulators
Read More
Chromocell reaches milestone in collaboration with Astellas
Read More
Phase I study of KL-1333 begins
Read More
Phase II data for voxelotor in pediatric sickle cell disease patients presented
Read More
Launch of Inter-Institutional Glial Biology Initiative
Read More
Heptares collaborates with New York University on GPCR target implicated in glioblastoma
Read More
TrovaGene submits IND for phase Ib/II study of PCM-075
Read More
KaloBios Pharmaceuticals' IND for benznidazole in Chagas disease now active
Read More
Hanmi's HM-15211 demonstrates benefit in Parkinson's disease and NASH models
Read More
Eptinezumab meets primary and key secondary endpoints in phase III PROMISE 1 study
Read More
Marinus Pharmaceuticals announces ganaxolone clinical program in postpartum depression
Read More
NantCell enters agreement to acquire Altor BioScience
Read More
RaNA Therapeutics now Translate Bio
Read More
Mepolizumab begins phase III trial in severe bilateral nasal polyps
Read More
Sandoz's Erelzi approved in Europe
Read More
Eisai withdraws Halaven submission in China with plans to resubmit
Read More
Araclon receives Spanish clearance for phase II trials of ABvac40 in early Alzheimer's
Read More
Phase III ECHELON-1 trial of Adcetris meets primary endpoint
Read More
Maximum tolerated dose determined in phase I study of Wnt pathway inhibitor ETC-159
Read More
Sun Pharma and Indian NIV partner on Zika, Chikungunya and dengue
Read More
Phase II trial of topical TV-45070 in post-herpetic neuralgia misses endpoints
Read More